Latest Health News

EV Resources has cleared a key technical review of its Tecomatlán processing plant in Mexico, setting the stage for near-term antimony concentrate production and pilot testing for its Los Lirios project.

Emyria Limited is scaling up its Perth Empax clinic with increased therapist approvals and treatment rooms, setting the stage for broader national clinical growth next year.

APA Group has announced a modest 1.9% increase in its interim distribution to 27.5 cents per security for the half year ending December 2025, maintaining steady income growth for investors.

McPherson’s Limited has unveiled a sweeping two-year transformation, streamlining its brand portfolio and adopting a scalable third-party logistics model to drive growth and improve financial stability.

Holista Colltech has received a formal notice from ASIC seeking recovery of approximately $1.09 million in legal costs related to Federal Court proceedings. The company is currently reviewing its options amid ongoing regulatory scrutiny.

Lindian Resources has awarded all major non-process infrastructure contracts for its Kangankunde Rare Earths Project in Malawi, marking a pivotal step toward first production in late 2026. Construction is underway with strong schedule confidence and capital discipline.

InhaleRx advances its clinical pipeline with a new oral treatment for resistant depression and plans a strategic rebrand to Nexalis Therapeutics, signaling a broader focus beyond inhaled therapies.

Anagenics Limited has announced a two-tranche placement to raise A$2.25 million, aiming to expand its health and wellness brands while retiring debt and supporting working capital.

Mayne Pharma has rejected Cosette Pharmaceuticals’ notice to terminate their merger agreement, citing Cosette’s failure to meet obligations that led to regulatory approval issues. The dispute raises fresh uncertainty over the proposed acquisition’s future.

4DMedical secures a key clinical adoption milestone as the University of Miami begins using its CT – VQ™ respiratory imaging technology, following Stanford’s lead. Meanwhile, Lahey Hospital inks a two-year deal for IQ-UIP™, underscoring growing traction in US academic medical centers.

Thrive Tribe Technologies has raised approximately $300,000 through a discounted share placement, aiming to strengthen its working capital position. The move reflects ongoing efforts to support its health and wellness digital platform amid a competitive market.

Jatcorp Limited has announced a fully underwritten pro-rata rights issue to raise approximately $4.2 million, aiming to strengthen working capital and accelerate growth in China and Southeast Asia. Eligible shareholders can subscribe at $0.15 per share with an option for additional shares under a Top-Up Facility.